Frederic Lemay
Overview
Explore the profile of Frederic Lemay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tremblay D, Joly-Mischlich T, Dufour A, Battista M, Berbiche D, Cote J, et al.
JMIR Res Protoc
. 2025 Jan;
14:e63099.
PMID: 39832166
Background: Telehomecare monitoring (TM) in patients with cancer is a complex intervention. Research shows variations in the benefits and challenges TM brings to equitable access to care, the therapeutic relationship,...
2.
Toure M, Sfairy S, Bedard S, McFadden N, Hanel R, Lemay F, et al.
Qual Life Res
. 2024 Apr;
33(6):1605-1619.
PMID: 38642218
Background: Because health resources are limited, health programs should be compared to allow the most efficient ones to emerge. To that aim, health utility instruments have been developed to allow...
3.
Tankel J, Ahmed N, Mueller C, Najmeh S, Spicer J, Mulder D, et al.
Ann Surg Oncol
. 2023 Dec;
31(4):2461-2469.
PMID: 38142255
Backround: Real-world, long-term survival outcomes of neoadjuvant, docetaxel-based therapy for esophageal and junctional adenocarcinoma are lacking. This study describes the long-term survival outcomes of patients with esophageal and junctional adenocarcinoma...
4.
Renouf D, Loree J, Knox J, Topham J, Kavan P, Jonker D, et al.
Nat Commun
. 2022 Aug;
13(1):5020.
PMID: 36028483
Immunotherapy-based monotherapy treatment in metastatic pancreatic ductal adenocarcinoma (mPDAC) has shown limited benefit outside of the mismatch repair deficiency setting, while safety and efficacy of combining dual-checkpoint inhibitor immunotherapy with...
5.
Smith A, Wong C, Cuggia A, Borgida A, Holter S, Hall A, et al.
JCO Precis Oncol
. 2022 Feb;
2:1-16.
PMID: 35135108
Purpose: We investigated the translational value of reflex testing for germline mutations in four homology-directed DNA repair predisposition genes (, , , and ) in consecutive patients with pancreatic adenocarcinoma....
6.
Jolivet C, Nassabein R, Soulieres D, Weng X, Amireault C, Ayoub J, et al.
Oncologist
. 2020 Dec;
26(4):e597-e602.
PMID: 33274825
Background: Fluoropyrimidines are used in chemotherapy combinations for multiple cancers. Deficient dihydropyrimidine dehydrogenase activity can lead to severe life-threatening toxicities. DPYD*2A polymorphism is one of the most studied variants. The...
7.
Levesque S, Lemay F, Bekal S, Frost E, Michaud S
JMM Case Rep
. 2017 Mar;
3(3):e005045.
PMID: 28348764
Introduction: Campylobacters are the most frequently identified bacteria causing diarrhoea in humans worldwide. was isolated for the first time in 2000 from faecal samples of two asymptomatic abattoir workers in...
8.
Lemay F, Cervera P, De Gramont A
Gastroenterology
. 2012 May;
142(7):1423, 1625.
PMID: 22543111
No abstract available.
9.
Giroux V, Lemay F, Bernatchez G, Robitaille Y, Carrier J
Int J Cancer
. 2008 May;
123(2):303-311.
PMID: 18464259
Clinical evidence suggests that estradiol replacement therapy reduces colon cancer risk in 'post'menopausal women. In colon epithelial cells, the estrogen receptor beta (ERbeta) is the predominant ER subtype and is...